Conformational Analysis and Structure-Activity Relationships of Selective Dopamine D-1 Receptor Agonists and Antagonists of the Benzazepine Series

Journal of Medicinal Chemistry

Volumn 33, Issue 8, 1990, Pages 2197-2204

  Pettersson, Ingrid ^a   Liljefors, Tommy ^b   Bøgesø, Klaus ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY   (Sweden)

^c H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 BENZAZEPINE DERIVATIVE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; THEORETICAL STUDY; THEORY;

BENZAZEPINES; CHEMISTRY, PHYSICAL; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; SCH-23390; SK&F-38393; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; THERMODYNAMICS;

EID: 0025326730     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00170a025     Document Type: Article

References (30)

1. Kebabian, J. W.; Caine, D. B. Nature (London) 1979, 277, 93.
2. For a review, see: Kaiser, C.; Jain, T. Med. Res. Rev. 1985,5, 145.
3. Kaiser, C.; Dandridge, P. A.; Garvey, E.; Hahn, R. A.; Sarau, H. M.; Setler, P. E.; Bass, L. S.; Clardy, J. J. Med. Chem. 1982, 25, 697.
4. O’Boyle, K. M.; Waddington, J. L. Eur. J. Pharmacol. 1984, 98, 433.
5. Hvttel, J. Eur. J. Pharmacol. 1983, 91, 153.
6. Iorio, L. C.; Barnett, A.; Leitz, F.; House, V.; Korduba, C. J. Pharmacol. Exp. Ther. 1983, 226, 462.
7. Billard, W.; Ruperto, V.; Crosby, G.; Iorio, L. C.; Barnett, A. Life Sci. 1984, 35, 1885.
8. Iorio, L. C.; Barnett, A.; Billard, W.; Gold, E. H. In Neurobiology of Central D1 Dopamine Receptors; Breese, G. R., Creese, I., Eds.; Plenum Press: New York, 1986; p 1.
9. Dandridge, P. A.; Kaiser, C.; Brenner, M.; Gaitanopoulus, D.; Davis, L. D.; Webb, R. L.; Foley, J. J.; Sarau, H. M. J. Med. Chem. 1984, 27. 28.
10. McDermed, J. D.; Freeman, H. S.; Ferris, R. M. In Catechol-amines: Basic and Clinical Frontiers; Usdin, E., Kopin, I., Barchas, J., Eds.; Pergamon: New York. 1979; Vol. 1. p 568.
11. Weinstock, J.; Oh, H.-J.; DeBrosse, C. W.; Egglestone, D. S.; Wise, M.; Flaim, K. E.; Gessner, G. W.; Sawyer, J. L.; Kaiser, C. J. Med. Chem. 1987, 30, 1303.
12. Van de Waterbeemd, H.; Carrupt, P.-E.; Testa, B., In QSAR in Drug Design and Toxicology; Hadzi, D., Jerman-Blazic, B., Eds.; Elsevier Science Publishers B.V.; Amsterdam, 1987; p 195.
13. Ladd, D. L.; Weinstock, J.; Wise, M.; Gessner, G. W.; Sawyer, J. L.; Flaim, K. E. J. Med. Chem. 1986, 29, 1904.
14. Nichols, D. E. In Dopamine Receptors; American Chemical Society symposium Series 224, American Chemical Society: Washington, DC, 1983; p 202.
15. Weinstock, J.; Ladd, D. L.; Wilson, J. W.; Brush, C. K.; Nelson, C. F. Y.; Gallagher, G., Jr.; McCarthy, M. E.; Silvestri, J.; Sarau, H. M.; Flaim, K. E.; Ackerman, D. M.; Setler, P. E.; Tobia, A. J.: Hahn, R. A. J. Med. Chem. 1986. 29. 2315.
16. Weinstock, J.; Hieble, J. P.; Wilson, J. W., III Drugs Future 1985, 10, 646.
17. Berger, J. C.; Chang, W. K.; Gold, E. H.; Clader, J. W. European Patent Appl. 871004461. 1987.
18. Braestrup, C.; Andersen, P. H.; Borrevang, P.; Gronvald, F. C.; Hansen, L. B.; Hohlweg, R. European Patent Appl. 86303001, 1986.
19. Barnett, A.; MacQuade, R.; Chipkin, R. In Pharmacology and Functional Regulation of Dopaminergic Neurons; Heart, P. M., Woodruff, G. N., Jackson, D. M., Eds.; The MacMillan Press Ltd: London, 1988; p 9.
20. Berger, J. G.; Chang, W. K.; Gold, E. H.; Clader, J. W. Rep. of South Africa Patent Appl. 875183, July 15, 1987.
21. Berger, J. G.; Chang, W. K.; Clader, J. W.; Hou, D.; Chipkin, R. E.; McPhail, A. T. J. Med. Chem. 1989, 32, 1913.
22. Burkert, U.; Allinger, N. L. Molecular Mechanics; American Chemical Society: Washington, DC, 1982, (The MM2/MMP2 programs are available from the Quantum Chemistry Program Exchange, University of Indiana, Bloomington, IN 47405 and from Molecular Design Ltd., 2132 Farallon Drive, San Leandro, CA 94577).
23. Sprague, J. T.; Tai, J. C.; Yuh, Y.; Allinger, N. L. J. Comput. Chem. 1987, 8, 581.
24. Liljefors, T.; Allinger, N. L. J. Comput. Chem. 1985, 6, 478.
25. Liljefors, T.; Tai, J. C.; Li, S.; Allinger, N. L. J. Comput. Chem. 1987. 8. 1051.
26. Pettersson, I.; Liljefors, T. J. Comput. Chem. 1987. 8. 1139.
27. Allinger, N. L.; Lii, J.-H. J. Comput. Chem. 1987, 8, 1146.
28. Allinger, N. L.; Kok, R. A.; Imam, M. R. J. Comput. Chem. 1988, 9, 591.
29. Liliefors, T. J. Mol. Graphics 1983, 1, 111.
30. Von der Lieth, C. W.; Carter, R. E.; Dolata, D. P.; Liljefors, T. J. Mol. Graphics 1984, 2, 117.